umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine
FOI, Umeå (Swedish Defence Research Agency).
Visa övriga samt affilieringar
2005 (Engelska)Ingår i: Infection and Immunity, ISSN 0019-9567, E-ISSN 1098-5522, Vol. 73, nr 12, s. 8345-8352Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Francisella tularensis subsp. tularensis (type A) strain SCHU S4 is a prototypic strain of the pathogen that is highly virulent for humans and other mammals. Its intradermal (i.d.) 50% lethal dose (LD50) for mice is <10 CFU. We discovered a spontaneous mutant, designated FSC043, of SCHU S4 with an i.d. LD50 of >10(8) CFU. FSC043 effectively vaccinated mice against challenge with a highly virulent type A strain, and the protective efficacy was at least as good as that of F. tularensis LVS, an empirically attenuated strain which has been used as an efficacious human vaccine. Comparative proteomics was used to identify two proteins of unknown function that were identified as defective in LVS and FSC043, and deletion mutants of SCHU S4 were created for each of the two encoding genes. One mutant, the DeltaFTT0918 strain, failed to express a 58-kDa protein, had an i.d. LD50 of approximately 10(5) CFU, and was found to be less capable than SCHU S4 of growing in peritoneal mouse macrophages. Mice that recovered from sublethal infection with the DeltaFTT0918 mutant survived when challenged 2 months later with >100 LD50s of the highly virulent type A strain FSC033. This is the first report of the generation of defined mutants of F. tularensis subsp. tularensis and their use as live vaccines.

Ort, förlag, år, upplaga, sidor
2005. Vol. 73, nr 12, s. 8345-8352
Nyckelord [en]
Administration; Cutaneous, Amino Acid Sequence, Animals, Bacterial Proteins/genetics/immunology, Bacterial Vaccines/administration & dosage/*genetics/immunology, Female, Francisella tularensis/genetics/*immunology/pathogenicity, Macrophages; Peritoneal/microbiology, Mice, Mice; Inbred BALB C, Molecular Sequence Data, Mutation, Proteomics, Skin/immunology, Tularemia/*prevention & control, Vaccines; Attenuated/administration & dosage/genetics/immunology, Virulence/genetics
Forskningsämne
klinisk bakteriologi
Identifikatorer
URN: urn:nbn:se:umu:diva-7351DOI: 10.1128/IAI.73.12.8345-8352.2005PubMedID: 16299332OAI: oai:DiVA.org:umu-7351DiVA, id: diva2:147022
Tillgänglig från: 2008-01-08 Skapad: 2008-01-08 Senast uppdaterad: 2018-06-09Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=16299332&dopt=Citation

Personposter BETA

Johansson, AndersLindgren, HelenaSvensson, KerstinZingmark, CarlSjöstedt, Anders

Sök vidare i DiVA

Av författaren/redaktören
Johansson, AndersLindgren, HelenaSvensson, KerstinZingmark, CarlSjöstedt, Anders
Av organisationen
Klinisk bakteriologiInfektionssjukdomar
I samma tidskrift
Infection and Immunity

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 222 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf